BULT A. | Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, University of Utrecht
スポンサーリンク
概要
- 同名の論文著者
- Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, University of Utrechtの論文著者
関連著者
-
BULT A.
Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, University of Utrecht
-
Rosing H
Netherlands Cancer Inst. Amsterdam Nld
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital/netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy Slotervaart Hospital
-
Beijnen J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
BULT Auke
Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences, Utrecht University
-
Bult Auke
Free University Amsterdam Department Of Analytical Chemistry And Applied Spectroscopy
-
Beijnen J.
Slotervaart Hospital/netherlands Cancer Institute
-
UNDERBERG W.
Department of Pharmaceutical Analysis, Faculty of Pharmacy, Utrecht University
-
Underberg W.
Department Of Pharmaceutical Analysis Faculty Of Pharmacy Utrecht University
-
Bult A.
Department Of Pharmaceutical Analysis Faculty Of Pharmacy Utrecht University
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Kaijser G.
Department Of Pharmaceutical Analysis Faculty Of Pharmacy Utrecht University
-
ROSING H.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
TEN BOKKEL
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute
-
BEIJNEN J.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
ROSING H.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
BEIJNEN J.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Jimeno J.
Pharma Mar S.a. Research And Development
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Ten Bokkel
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Beijnen J.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Floriano P.
Pharmamar S.a. Research And Development
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
KEIZER H.
Department of Clinical Oncology, University Hospital Leiden
-
Keizer H.
Department Of Clinical Oncology University Hospital Leiden
-
HILLEBRAND M.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital/Netherlands Cancer Institute
-
GOMEZ A.
Pharma Mar, S.A., Research and Development
-
FAIRCLOTH G.
Pharma Mar, S.A., Research and Development
-
CAMERON L.
Pharma Mar, S.A., Research and Development
-
HENRAR R.
EORTC-New Drug Development Office
-
VERMORKEN J.
Department of Medical Oncology, University Hospital Antwerpen
-
VAN ZOMEREN
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
DOYLE E.
Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals
-
Van Zomeren
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Doyle E.
Department Of Drug Analysis Smithkline Beecham Pharmaceuticals
-
Meenhorst P.
Department Of Internal Medicine Slotervaart Hospital
-
Faircloth G.
Pharma Mar S.a. Research And Development
-
Vermorken J.
Department Of Medical Oncology University Hospital Antwerpen
-
Hillebrand M.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
KOKS C.
Department of Pharmacy, Slotervaart Hospital
-
KAIJSER G.
Department of Pharmaceutical Analysis, Faculty of Pharmacy, Utrecht University
-
KAIJSER G.
RL-CERM, Zone Industrielle "La Varenne"
-
ROZENDOM E.
Department of Pharmaceutical Analysis, Faculty of Pharmacy, Utrecht University
-
Cameron L.
Pharma Mar S.a. Research And Development
-
Koks C.
Department Of Pharmacy Slotervaart Hospital
-
Gomez A.
Pharma Mar S.a. Research And Development
-
Rozendom E.
Department Of Pharmaceutical Analysis Faculty Of Pharmacy Utrecht University
著作論文
- Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients
- Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urine
- Analysis of ifosforamide mustard, the active metabolite of ifosfamide, in plasma